drugset / Trial / NCT00005990

R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors

NCT00005990

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of R115777 plus topotecan in treating patients who have advanced solid tumors.

Timeline

Start
2000-08
Primary completion
2006-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Topotecan Small molecule Intravenous
Subject tipifarnib Small molecule Oral